Atlantic Healthcare raises $24m from LDC et al.

In addition to LDC, the founders of Salix Pharmaceuticals participated, as did the family office Fullbrook Thorpe Investments and existing investors Envestors and the Angel Co-Fund.

The capital injection will support the phase-3 clinical trials of Atlantic's alicaforsen product for the treatment of pouchitis and other inflammatory bowel diseases, as well as filing for regulatory approval of the product in North America and Europe.

The investment is the third round of funding raised by Atlantic Healthcare, having received €1.5m from Envestors and others in November 2010, followed by an undisclosed injection from the Angel Co-Fund in 2013.

Company
Founded in 2006, Atlantic Healthcare is a developer of speciality pharmaceuticals, based in Cambridge.

People
LDC – John Green (investment director).
Atlantic Healthcare – Toby Wilson Waterworth (CEO, founder).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Healthcare
• Early-stage
• UK / Ireland
• Pharmaceuticals
• LDC
• United Kingdom